Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7577431

Concept 2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
417,000,000 JPY
5,418,000,000 JPY
5,809,000,000 JPY
-767,000,000 JPY
5,041,000,000 JPY
-26,000,000 JPY
4,677,000,000 JPY
5,173,000,000 JPY
-495,000,000 JPY
329,000,000 JPY
4,886,000,000 JPY
-42,000,000 JPY
Non-operating income
Non-operating income
402,000,000 JPY
367,000,000 JPY
Non-operating expenses
Non-operating expenses
197,000,000 JPY
254,000,000 JPY
Ordinary profit (loss)
5,246,000,000 JPY
4,790,000,000 JPY
Extraordinary income
Extraordinary income
121,000,000 JPY
9,425,000,000 JPY
Extraordinary losses
Extraordinary losses
JPY
8,366,000,000 JPY
Profit (loss) before income taxes
5,367,000,000 JPY
5,849,000,000 JPY
Income taxes - current
1,036,000,000 JPY
1,048,000,000 JPY
Income taxes - deferred
148,000,000 JPY
717,000,000 JPY
Profit (loss)
4,183,000,000 JPY
4,082,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.